These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 29950539)

  • 1. Current Diagnosis and Management of Graves' Disease.
    Subekti I; Pramono LA
    Acta Med Indones; 2018 Apr; 50(2):177-182. PubMed ID: 29950539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association.
    Nagayama Y; Izumi M; Nagataki S
    Endocrinol Jpn; 1989 Apr; 36(2):299-314. PubMed ID: 2476301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 2011 survey of clinical practice patterns in the management of Graves' disease.
    Burch HB; Burman KD; Cooper DS
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4549-58. PubMed ID: 23043191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
    Bahn RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
    Endocr Pract; 2011; 17(3):456-520. PubMed ID: 21700562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathogenesis and management of Grave's ophthalmopathy].
    Wierzbowska J; Stankiewicz A
    Klin Oczna; 2002; 104(2):147-53. PubMed ID: 12174459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
    Bahn Chair RS; Burch HB; Cooper DS; Garber JR; Greenlee MC; Klein I; Laurberg P; McDougall IR; Montori VM; Rivkees SA; Ross DS; Sosa JA; Stan MN; ;
    Thyroid; 2011 Jun; 21(6):593-646. PubMed ID: 21510801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International differences in approaches to 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China.
    Tominaga T; Yokoyama N; Nagataki S; Cho BY; Koh CS; Chen JL; Shi Y
    Thyroid; 1997 Apr; 7(2):217-20. PubMed ID: 9133688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.
    Ross DS; Burch HB; Cooper DS; Greenlee MC; Laurberg P; Maia AL; Rivkees SA; Samuels M; Sosa JA; Stan MN; Walter MA
    Thyroid; 2016 Oct; 26(10):1343-1421. PubMed ID: 27521067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune diseases of the thyroid gland].
    Allelein S; Feldkamp J; Schott M
    Internist (Berl); 2017 Jan; 58(1):47-58. PubMed ID: 28074218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States.
    Wartofsky L; Glinoer D; Solomon B; Nagataki S; Lagasse R; Nagayama Y; Izumi M
    Thyroid; 1991; 1(2):129-35. PubMed ID: 1688014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Grave's disease in 2009].
    Philippe J
    Rev Med Suisse; 2009 Apr; 5(198):764-8. PubMed ID: 19418977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of management of Graves' disease in District General Hospital: achievement of consensus guidelines.
    Dasgupta S; Savage MW
    Int J Clin Pract; 2005 Sep; 59(9):1097-100. PubMed ID: 16115188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic procedure in suspected Graves' disease.
    Goichot B; Leenhardt L; Massart C; Raverot V; Tramalloni J; Iraqi H;
    Ann Endocrinol (Paris); 2018 Dec; 79(6):608-617. PubMed ID: 30220410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey.
    Hookham J; Collins EE; Allahabadia A; Balasubramanian SP
    Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Graves' disease: an overview and comparison of clinical practice guidelines with actual practice trends.
    Muldoon BT; Mai VQ; Burch HB
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):495-516. PubMed ID: 24891174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid microcarcinoma in a boy with Graves' disease: a case report and review of the literature.
    Tuli G; Munarin J; Tessaris D; Quaglino F; de Sanctis L
    Pediatr Endocrinol Diabetes Metab; 2022; 28(1):88-90. PubMed ID: 34928110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Important considerations in the management of Graves' disease in pregnant women.
    Okosieme OE; Lazarus JH
    Expert Rev Clin Immunol; 2015; 11(8):947-57. PubMed ID: 26041458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
    Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
    Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.